Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Learn various ways to invest smartly this year, ensuring your financial growth and stability in 2023.
22,737 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Oil hovers around $101 per barrel on March 23, 2026, after a sharp drop from yesterday. Traders weigh demand trends, ...
NVIDIA stock is under pressure as a wave of AI infrastructure spending by the Magnificent Seven tests profits versus ...
PennantPark Investment’s hefty yield hinges on a reserve that funds part of its payouts and a portfolio heavy in floa...
Argus boosts Exxon Mobil's target to $169, signaling confidence in higher 2026 output from Permian and Guyana and a r...
A $2.9 billion closed-end fund has paid distributions every year since 2000, marking a 26-year streak. Here’s how the...
A family estate in a hot real estate market yields a six-figure tax surprise when an inherited home’s stepped-up basi...
A rising iPhone upgrade cycle is quietly lifting a little-known stock. This article breaks down why the move makes it...
Publishers, printers, and retailers are adapting to inflation, backlogs, and shifting demand as the journey from prop...
As BioHarvest gears up for its Q1 2026 earnings, investors seek clarity on revenue momentum, margins, and the path to...
As Kolibri wraps its Q4 2025 results, investors seek clarity on growth, margins, and cash flow. This article translat...